Literature DB >> 10412039

Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro.

R O Oreffo1, S Romberg, A S Virdi, C J Joyner, S Berven, J T Triffitt.   

Abstract

The specific effects of interferon alpha (IFNalpha), on the differentiation pathways of human osteogenic cells are not known. The aim of this study was to investigate possible effects of IFNalpha on osteogenic development by investigating cell differentiation, colony formation (colony forming unit-fibroblastic, CFU-F), cell proliferation, and gene expression, in particular bone morphogenetic protein (BMP) expression, of human bone marrow osteoprogenitor cells. Human bone marrow fibroblasts were cultured with or without the addition of IFNalpha (5-1,000 IU/ml) in the presence and absence of dexamethasone (10 nM) and ascorbate (100 microM), which are agents known to affect osteogenic differentiation. IFNalpha produced a significant dose-dependent inhibition of cell proliferation and alkaline phosphatase specific activity at concentrations as low as 50 IU/ml. IFNalpha (50-1,000 IU/ml) inhibited the stimulation of alkaline phosphatase specific activity induced by ascorbate and dexamethasone. Examination of CFU-F showed dose- and time-dependent inhibitions of colony formation and reductions in both colony size and alkaline phosphatase-positive CFU-F colonies particularly at earlier times. Reactivity with an antibody specific for osteoprogenitors (HOP-26), was reduced in IFNalpha-treated cultures. Northern blot analysis showed a significant dose-dependent up-regulation of BMP-2 mRNA, estrogen receptor alpha mRNA and osteocalcin mRNA expression in ascorbate/dexamethasone cultures. In contrast, IFNalpha significantly inhibited BMP-2 mRNA expression in the absence of ascorbate and dexamethasone. In conclusion, IFNalpha inhibits human osteoprogenitor cell proliferation, CFU- F formation, HOP-26 expression, and alkaline phosphatase specific activity and modulates BMP-2 gene expression. These results suggest a role for IFNalpha in local bone turnover through the specific and direct modulation of osteoprogenitor proliferation and differentiation. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412039     DOI: 10.1002/(sici)1097-4644(19990901)74:3<372::aid-jcb6>3.3.co;2-8

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  The regulation-of-autophagy pathway may influence Chinese stature variation: evidence from elder adults.

Authors:  Feng Pan; Xiao-Gang Liu; Yan-Fang Guo; Yuan Chen; Shan-Shan Dong; Chuan Qiu; Zhi-Xin Zhang; Qi Zhou; Tie-Lin Yang; Yan Guo; Xue-Zhen Zhu; Hong-Wen Deng
Journal:  J Hum Genet       Date:  2010-05-07       Impact factor: 3.172

Review 2.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Tatjana Stojakovic; Georg Biesenbach; Jörg Berg
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

4.  Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD.

Authors:  Lishu Zhang; Yan-Fang Guo; Yao-Zhong Liu; Yong-Jun Liu; Dong-Hai Xiong; Xiao-Gang Liu; Liang Wang; Tie-Lin Yang; Shu-Feng Lei; Yan Guo; Han Yan; Yu-Fang Pei; Feng Zhang; Christopher J Papasian; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

Review 5.  Regulation of Osteoblast Differentiation by Cytokine Networks.

Authors:  Dulshara Sachini Amarasekara; Sumi Kim; Jaerang Rho
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

Review 6.  Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?

Authors:  Jehan J El-Jawhari; Yasser El-Sherbiny; Dennis McGonagle; Elena Jones
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

7.  Bone metabolism during interferon-alpha treatment of essential thrombocythemia.

Authors:  Rajko Kusec; Vesna Kusec; Bettina Gisslinger; Wolfgang Woloszczuk; Heinz Gisslinger
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.